AstraZeneca Canada Inc. v. Apotex Inc.

Drug: NEXIUM esomeprazole

This was an appeal of a decision of the Federal Court, refusing an interlocutory motion. The Federal Court decision is summarized here.

The Court of Appeal held that the decision of the Federal Court was based in large part on factual findings. The Court of Appeal found that the Federal Court did not set the bar too high for a finding of irreparable harm, and that no reviewable error was made.